via Springerlink;
Long-Term (3-Year) Neurocognitive Effectiveness Of Antipsychotic Medications In First Episode Non-Affective Psychosis: A Randomized Comparison Of Haloperidol, Olanzapine, and Risperidone.
"The major conclusion of this study is that haloperidol, olanzapine, and risperidone have not demonstrated substantial neurocognitive effectiveness, improving cognitive deficits present in the early phases of the illness. The study also underscores the importance of exploring new drugs for the treatment of cognitive impairments and associated functional disabilities in schizophrenia."
How many more of these studies is it going to take before we pull the funding plug on this Psychiatric, chemical mind and mood control scam?
The Eli Lilly Zyprexa saga,a criminal conspiracy from the get-go
ReplyDeleteEli Lilly has made $70 billion on Zyprexa (Olanzapine) and it was way oversold and caused diabetes and in some cases sudden death.
Still making $1.5 billion year on the Zyprexa franchise.
Eight Lilly employees who are supposed ‘whistleblowers’ got $10 million each payouts, the real victims like me were ignored. Law firms on both sides of the aisle made tens of millions.
I am a living example of Zyprexa gone/done wrong was given it 1996-2000 off-label for PTSD got sudden high blood sugar A1C 14.7 in January 2000.The stuff was worthless for my condition PTSD and cost me thousands in co-pays gave me diabetes.
–
Daniel Haszard